Dow Up 0.51% Nasdaq Up 0.24%

ArQule Inc. (ARQL)

-NasdaqGM
1.26 Down 0.02(1.56%) 4:00PM EST
Prev Close:1.28
Open:1.30
Bid:1.26 x 700
Ask:1.29 x 2500
1y Target Est:1.63
Beta:1.82
Next Earnings Date:N/A
Day's Range:1.26 - 1.30
52wk Range:1.04 - 2.92
Volume:296,512
Avg Vol (3m):260,078
Market Cap:79.09M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARQLDown 1.56%79.09M
ARRYUp 1.35%496.18M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback